HBIO- Harvard Bioscience, Inc.

Name: Harvard Bioscience, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Harvard Bioscience, Inc. (HBIO) has 8 insiders with recent SEC Form 4 filings, including 13 buys and 4 sells. HBIO is classified in the Health Care Equipment & Supplies industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Green James W	2.80M	$18.99M	-
Dir	Eade Katherine A.	421.1K	$2.86M	-
CEO	Duke John D	180.0K	$1.22M	-
Dir	Benson Seth Benjamin	110.0K	$746.9K	-
Dir	Gagnon Robert E.	110.0K	$746.9K	-

Activity

Buys and sells only

Transactions

10 filings · page 3

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 12, 2021	Green James W70	Chief Executive Officer	Sell	35,000	$5.98	$209,300.00	-1.5%	+15.4%	-7.2%
Jun 12, 2020	Edrick Alan I57	Director	Buy	20,000	$2.63	$52,500.00	+42.1%	-	-
May 7, 2020	Green James W70	Chief Executive Officer	Buy	10,000	$2.53	$25,300.00	+0.7%	-	-
Nov 13, 2019	Loy Bertrand69	Director	Buy	36,150	$2.56	$92,685.98	+5.3%	-	-
Nov 11, 2019	Green James W70	Chief Executive Officer	Buy	10,000	$2.61	$26,100.00	+0.7%	-	-
Sep 13, 2019	Loy Bertrand69	Director	Buy	34,259	$3.05	$104,534.61	+8.3%	-	-
Aug 20, 2019	Loewald Thomas W	Director	Buy	20,000	$2.53	$50,524.00	+24.0%	-	-
Aug 16, 2019	Green James W70	Chief Executive Officer	Buy	10,000	$2.49	$24,850.00	+0.7%	-	-
Aug 9, 2019	Eade Katherine A.	Director	Buy	39,915	$2.48	$98,829.54	+48.9%	-	-
Apr 12, 2019	Duchemin Jeffrey	Chief Executive Officer	Sell	19,157	$4.51	$86,390.75	-0.8%	-	-

← PrevPage 3Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC